Impact of high risk molecular mutations after allogenic transplantation in myelofibrosis: long term results of a prospective GITMO clinical trial

被引：0
|
作者：
Salmoiraghi, S. [1 ]
Patriarca, F. [2 ]
Civini, A. [1 ]
Pavoni, C. [1 ]
Finazzi, M. C. [1 ]
Guglielmelli, P. [3 ]
Narni, F. [4 ]
Rumi, E. [5 ]
Russo, D. [6 ]
Messina, G. [7 ]
Bregante, S. [8 ]
Milone, G. [9 ]
Imovilli, A. [10 ]
Benedetto, B. [11 ]
Musso, M. [12 ]
Santarone, S. [13 ]
Pini, M. [14 ]
Corra-Dini, P. [15 ,16 ]
Spinelli, O. [1 ]
Bonifazi, F. [17 ]
Rambaldi, A. [1 ,16 ]
机构：
[1] ASST Papa Giovanni XXIII, Bergamo, Italy
[2] AOU Santa Maria Misericordia, Udine, Italy
[3] AOU Careggi, Florence, Italy
[4] Univ Modena, Modena, Italy
[5] Policlin San Matteo, Pavia, Italy
[6] AO Spedali Civili, Brescia, Italy
[7] Bianchi Melacrino Morelli Hosp, Reggio Di Calabria, Italy
[8] IRCCS Osped Policlin San Martino, Genoa, Italy
[9] Ferrarotto Hosp, Catania, Italy
[10] Arciospedale S Maria Nuova, Reggio Emilia, Italy
[11] Citta Salute Scienza, Turin, Italy
[12] La Maddalena, Palermo, Italy
[13] Osped Civile, Pescara, Italy
[14] AOSS Antonio Biagio, Alessandria, Italy
[15] Istituto Nazl Tumori, Milan, Italy
[16] Univ Milan, Milan, Italy
[17] IRCCS AOU Bologna, Bologna, Italy
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O111
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [1] Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
    Tamari, Roni
    Rapaport, Franck
    Zhang, Nan
    McNamara, Caroline
    Kuykendall, Andrew
    Sallman, David A.
    Komrokji, Rami
    Arruda, Andrea
    Najfeld, Vesna
    Sandy, Lonette
    Medina, Juan
    Litvin, Rivka
    Famulare, Christopher A.
    Patel, Minal A.
    Maloy, Molly
    Castro-Malaspina, Hugo
    Giralt, Sergio A.
    Weinberg, Rona S.
    Mascarenhas, John O.
    Mesa, Ruben
    Rondelli, Damian
    Dueck, Amylou C.
    Levine, Ross L.
    Gupta, Vikas
    Hoffman, Ronald
    Rampal, Raajit K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (06) : 1142 - 1151
  • [2] PROSPECTIVE VALIDATION OF THE PROGNOSTIC IMPACT OF HIGH MOLECULAR RISK MUTATIONS AFTER ALLOGENEIC STEM CELL TRANSPLATION IN MYELOFIBROSIS
    Finazzi, Maria Chiara
    Civini, Alessia
    Pavoni, Chiara
    Grassi, Anna
    Mico, Maria Caterina
    Algarotti, Alessandra
    Patriarca, Francesca
    Guglielmelli, Paola
    Luppi, Mario
    Rumi, Elisa
    Polverelli, Nicola
    Messina, Giuseppe
    Bregante, Stefania
    Milone, Giuseppe
    Imovilli, Annalisa
    Bruno, Benedetto
    Musso, Maurizio
    Santarone, Stella
    Pennisi, Martina
    Spinelli, Orietta
    Bonifazi, Francesca
    Rambaldi, Alessandro
    Salmoiraghi, Silvia
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 112 - 113
  • [3] Training and Validation Cohorts for Predicting the Impact of High Molecular Risk Mutations after Allogeneic Stem Cell Transplantation in Myelofibrosis
    Finazzi, Maria Chiara
    Civini, Alessia
    Pavoni, Chiara
    Grassi, Anna
    Mico, Maria Caterina
    Algarotti, Alessandra
    Bellini, Marta
    Patriarca, Francesca
    Guglielmelli, Paola
    Luppi, Mario
    Rumi, Elisa
    Polverelli, Nicola
    Messina, Giuseppe
    Bregante, Stefania
    Milone, Giuseppe
    Imovilli, Annalisa
    Bruno, Benedetto
    Musso, Maurizio
    Santarone, Stella
    Pini, Massimo
    Pennisi, Martina
    Spinelli, Orietta
    Bonifazi, Francesca
    Rambaldi, Alessandro
    Salmoiraghi, Silvia
    BLOOD, 2022, 140 : 10622 - 10623
  • [4] LONG-TERM RESULTS OF ISLET ALLOGENIC TRANSPLANTATION AND PRIMARY GRAFT FUNCTION IMPACT
    Chetboun, M.
    Hubert, T.
    Kerr-Conte, J.
    Caiazzo, R.
    Raverdy, V.
    Gmyr, V.
    Vantyghem, M. C.
    Pattou, F.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 1 - 1
  • [5] Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial
    Popat, Uday
    Mehta, Rohtesh S.
    Bassett, Roland
    Kongtim, Piyanuch
    Chen, Julianne
    Alousi, Amin M.
    Anderlini, Paolo
    Ciurea, Stefan
    Hosing, Chitra
    Jones, Roy
    Kebriaei, Partow
    Khouri, Issa
    Pa, Richard Lindsay
    Nieto, Yago
    Olson, Amanda
    Oran, Betul
    Qazilbash, Muzaffar H.
    Rondon, Gabriela
    Shpall, Elizabeth J.
    Verstovsek, Srdan
    Andersson, Borje S.
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) : 1439 - 1445
  • [6] Impact of CMV Viremia After Liver Transplantation: 15 Year Results of a Prospective, Randomized Clinical Trial
    Struecker, B.
    Seehofer, D.
    Andreas, A.
    Neuhaus, P.
    Nada, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 773 - 773
  • [7] Impact of Infections on Long-Term Results after Heart Transplantation
    Doesch, A. O.
    THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 : S154 - S155
  • [8] Impact of CMV Viremia After Liver Transplantation: 15 Year Results of a Prospective, Randomized Clinical Trial.
    Struecker, B.
    Seehofer, D.
    Andreas, A.
    Neuhaus, P.
    Nada, R.
    TRANSPLANTATION, 2014, 98 : 773 - 773
  • [9] IMPACT OF ILOPROST ON EARLY GRAFT VIABILITY AFTER LIVER TRANSPLANTATION - RESULTS OF A PROSPECTIVE RANDOMIZED CONTROLLED CLINICAL TRIAL
    Baerthel, Erik
    Rachfuss, Falk
    Habrecht, Olaf
    Koch, Alexander
    Klinzing, Stefan
    Marx, Gernot
    Kornberg, Arno
    Settmacher, Utz
    LIVER TRANSPLANTATION, 2008, 14 (07) : S137 - S137
  • [10] LONG-TERM RESULTS OF RENAL TRANSPLANTATION IN HIGH RISK PATIENTS
    Denisov, Viktor
    Zakharov, Vadim
    Oleshchenko, Nikolay
    Onishchenko, Evgeny
    Sidorkin, Alexander
    Golubova, Tatyana
    Kichatyi, Sergey
    Zakharova, Olga
    TRANSPLANT INTERNATIONAL, 2015, 28 : 390 - 390
12345